Another study group evaluated 236 Ashkenazi Jewish PD patients in four different groups based on their mutation profile: LRRK2-PD, GBA1, GBA1-LRRK2-PD, and mutation-negative PD (MNPD). Here, GBA1 is linked to Parkinson disease.